A trial of caspofungin salvage treatment in PCP pneumonia

被引：49

作者：

Armstrong-James, Darius ^{[1
,2
]}

Stebbing, Justin ^{[1
]}

John, Laurence ^{[1
,3
]}

Murungi, Andrew ^{[1
]}

Bower, Mark ^{[1
]}

Gazzard, Brian ^{[1
]}

Nelson, Mark ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, St Stephens AIDS Trust, Chelsea & Westminister Hosp, London W12 0NN, England

[2] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London W12 0NN, England

[3] Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England

来源：

THORAX | 2011年 / 66卷 / 06期

关键词：

PNEUMOCYSTIS-CARINII; L-743,872; THERAPY;

D O I：

10.1136/thx.2010.135350

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：537 / 538

页数：4

共 11 条

[1]

Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation [J].

Annaloro, C ;

Della Volpe, A ;

Usardi, P ;

Deliliers, GL .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) :52-54

[2]

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) [J].

Bartizal, K ;

Gill, CJ ;

Abruzzo, GK ;

Flattery, AM ;

Kong, L ;

Scott, PM ;

Smith, JG ;

Leighton, CE ;

Bouffard, A ;

Dropinski, JF ;

Balkovec, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2326-2332

[3]

De Stefano JA, 1998, J EUKARYOT MICROBIOL, V45, P334, DOI 10.1111/j.1550-7408.1998.tb04545.x

[4]

Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080

[5]

Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study [J].

Fei, M. W. ;

Kim, E. J. ;

Sant, C. A. ;

Jarlsberg, L. G. ;

Davis, J. L. ;

Swartzman, A. ;

Huang, L. .

THORAX, 2009, 64 (12) :1070-1076

[6]

Adverse reactions to trimethoprim/sulfamethoxazole in AIDS [J].

Floris-Moore, MA ;

Amodio-Groton, MI ;

Catalano, MT .

ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) :1810-1813

[7]

Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy [J].

Hof, H. .

MYCOSES, 2008, 51 :1-6

[8]

Cell wall assembly by Pneumocystis carinii -: Evidence for a unique Gsc-1 subunit mediating β-1,3-glucan deposition [J].

Kottom, TJ ;

Limper, AH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40628-40634

[9]

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy [J].

Miller, R. F. ;

Allen, E. ;

Copas, A. ;

Singer, M. ;

Edwards, S. G. .

THORAX, 2006, 61 (08) :716-721

[10]

Efficacy of MK-991 (L-743,872), a semisynthetic pneumocandin, in murine models of Pneumocystis carinii [J].

Powles, MA ;

Liberator, P ;

Anderson, J ;

Karkhanis, Y ;

Dropinski, JF ;

Bouffard, FA ;

Balkovec, JM ;

Fujioka, H ;

Aikawa, M ;

McFadden, D ;

Schmatz, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1985-1989

← 1 2 →